Corresponding Author: Kimberly G. Blumenthal, MD, MSc, The Mongan Institute, Massachusetts General Hospital, 100 Cambridge St, 16th Floor, Boston, MA 02114 (email@example.com).
Published Online: April 14, 2022. doi:10.1001/jama.2022.5247
Conflict of Interest Disclosures: Dr Freeman reported receiving grants from the International League of Dermatologic Societies COVID-19 Dermatology Registry and National Institutes of Health (NIH) (K23); receiving royalties from UpToDate; and receiving in-kind support from the American Academy of Dermatology for the COVID-19 Dermatology Registry. Dr Blumenthal reported receiving grants from the Massachusetts General Hospital Transformative Scholar Award, Executive Committee on Research, COVID-19 Junior Investigator Support Initiative, Agency for Healthcare Research and Quality (R01HS025375), and NIH (R01 AI150295); receiving royalties from UpToDate; and receiving personal fees from Weekley, Schulte, Valdes, Murman, and Tonelli; Vasios, Kelly, and Strollo; and Piedmont Liability Trust. No other disclosures were reported.
Additional Information: We thank the patient for providing permission to share her information.
T , Abdul Latiff
AH , Abuzakouk
et al. The international EAACI/GA2
LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy
. 2022;77(3):734-766. doi:10.1111/all.15090PubMedGoogle ScholarCrossref
P , Kim
W , Paley
et al. Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study. Ann Intern Med
. 2021;174(11):1572-1585. doi:10.7326/M21-1757PubMedGoogle ScholarCrossref
RAK , Janagama
R , Peruru
et al. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J Med Virol
. 2021;93(7):4420-4429. doi:10.1002/jmv.26996PubMedGoogle ScholarCrossref